Quince Therapeutics, Inc. QNCX
31.00
1.00
3.33%
as of 25 Sep
- Market cap
- $30.5M
- P/E
- 0.0×
Follow QNCX
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
4.28 | 49.82 | 11.93 | 8.11 | 7.85 | 30.55 | 8.09 | 6.05 | 0.53 |
Net Debt/EBITDA |
0.02 | 5.77 | 2.51 | 1.71 | 1.19 | 1.76 | 2.03 | 0.63 | 0.00 |
Debt/Assets |
92.91% | 0.00% | 0.00% | 0.24% | 0.87% | 0.44% | 8.00% | 12.51% | 19.27% |
Debt/Equity |
(0.35) | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.16 | 0.48 | (0.50) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.80 | 0.94 | 0.90 | 0.66 | 0.70 | 0.85 | 0.58 | 0.56 | 0.49 |
Capex/Depreciation |
(1.71) | 0.71 | 0.09 | (0.05) | (0.15) | (0.07) | (0.02) | (0.02) | 0.40 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 46.25% | 47.16% | (89.27%) | (53.42%) | (61.85%) | (47.14%) | (33.81%) | (98.63%) | 3,016.49% | |
| (30.36%) | (30.96%) | (37.50%) | (48.97%) | (55.75%) | (43.57%) | (23.09%) | (40.25%) | (80.75%) | |
ROIC |
0.00% | 0.00% | (156.78%) | (126.80%) | (436.07%) | (299.21%) | (92.26%) | (972.12%) | 0.00% |
Return on Tangible Assets |
(207.51%) | (17.47%) | (37.78%) | (63.36%) | (92.05%) | (56.72%) | (46.09%) | (153.29%) | 425.53% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.48 | 0.52 | 0.73 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(600.24) | (708.75) | (350.13) | (348.66) | (424.71) | (263.29) | (98.61) | (148.69) | (166.77) |
Cash per Share |
448.06 | 4,268.81 | 1,048.99 | 917.20 | 718.72 | 538.39 | 403.11 | 188.55 | 70.87 |
Shareholders Equity per Share |
(1,229.09) | (1,942.02) | 1,213.00 | 1,180.69 | 798.02 | 600.56 | 456.95 | 139.37 | (142.57) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1,229.09) | (1,942.02) | 1,213.00 | 1,180.69 | 798.02 | 600.56 | 456.95 | 139.37 | (142.57) |
Free Cash Flow |
(9.90) | (11.91) | (33.33) | (50.87) | (63.11) | (44.10) | (18.36) | (32.16) | (41.78) |
Working Capital |
5.77 | 71.13 | 97.16 | 120.87 | 97.45 | 90.68 | 67.87 | 36.76 | (20.33) |
Capital Expenditures |
(0.08) | (0.21) | (0.05) | (0.05) | (0.18) | (0.06) | (0.07) | (0.26) | (0.35) |
Net Current Asset Value |
(20.46) | (32.92) | 97.16 | 120.66 | 97.03 | 90.43 | (5.38) | (40.30) | (106.34) |
| Other line items | |||||||||
Quick Ratio |
4.19 | 49.22 | 11.23 | 7.87 | 7.51 | 29.38 | 7.84 | 5.60 | 0.41 |
Depreciation/Fixed assets |
0.37 | (1.06) | (0.88) | 2.26 | 4.65 | 2.33 | 17.96 | 47.52 | (1.47) |
Cash ROIC |
174.06% | (30.64%) | (15.78%) | (16.72%) | (27.89%) | (23.23%) | (10.67%) | (37.79%) | (65,656.25%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(595.58) | (696.13) | (349.55) | (348.31) | (423.50) | (262.91) | (98.24) | (147.50) | (165.37) |
Capex per Share |
(4.67) | (12.62) | (0.58) | (0.36) | (1.21) | (0.38) | (0.38) | (1.19) | (1.41) |
Average Payables |
0.51 | 0.51 | 1.79 | 3.32 | 4.23 | 2.74 | 1.30 | 2.47 | 2.56 |
Average Assets |
40.30 | 40.30 | 98.62 | 156.92 | 161.35 | 118.57 | 135.91 | 141.19 | 104.00 |
Average Common Equity |
(26.45) | (26.45) | 41.43 | 143.87 | 145.42 | 109.59 | 92.84 | 57.62 | (2.78) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates